Homeopathic Drug Product Safety, Quality, and Transparency Act

[AI summary unavailable — showing source text] [Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 7050 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 7050 To amend the Federal Food, Drug, and Cosmetic Act with respect to homeopathic drug products, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES January 14, 2026 Mr. Sessions (for himself, Mr. Kennedy of Utah, and Mr. Jackson of Illinois) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To amend the Federal Food, Drug, and Cosmetic Act with respect to homeopathic drug products, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE; TABLE OF CONTENTS. (a) Short Title.--This Act may be cited as the ``Homeopathic Drug Product Safety, Quality, and Transparency Act''. (b) Table of Contents.--The table of contents for this Act is as follows: Sec. 1. Short title; table of contents. Sec. 2. Purpose; sense of Congress. Sec. 3. Def…